Chimenti S - Search Results

1

Allele-specific cytokine responses at the HLA-C locus: implications for psoriasis.

Hundhausen C, Bertoni A, Mak RK, Botti E, Di Meglio P, Clop A, Laggner U, Chimenti S, Hayday AC, Barker JN, Trembath RC, Capon F, Nestle FO. Hundhausen C, et al. Among authors: chimenti s. J Invest Dermatol. 2012 Mar;132(3 Pt 1):635-41. doi: 10.1038/jid.2011.378. Epub 2011 Nov 24. J Invest Dermatol. 2012. PMID: 22113476 Free PMC article.

2

Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers.

Costanzo A, Talamonti M, Botti E, Spallone G, Papoutsaki M, Chimenti S. Costanzo A, et al. Among authors: chimenti s. Dermatology. 2009;219(1):48-53. doi: 10.1159/000213758. Epub 2009 Apr 16. Dermatology. 2009. PMID: 19372639

3

Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab.

Talamonti M, Botti E, Galluzzo M, Teoli M, Spallone G, Bavetta M, Chimenti S, Costanzo A. Talamonti M, et al. Among authors: chimenti s. Br J Dermatol. 2013 Aug;169(2):458-63. doi: 10.1111/bjd.12331. Br J Dermatol. 2013. PMID: 23521149

4

Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.

Chiricozzi A, Guttman-Yassky E, Suárez-Fariñas M, Nograles KE, Tian S, Cardinale I, Chimenti S, Krueger JG. Chiricozzi A, et al. Among authors: chimenti s. J Invest Dermatol. 2011 Mar;131(3):677-87. doi: 10.1038/jid.2010.340. Epub 2010 Nov 18. J Invest Dermatol. 2011. PMID: 21085185 Free article.

5

Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target.

Botti E, Spallone G, Caruso R, Monteleone G, Chimenti S, Costanzo A. Botti E, et al. Among authors: chimenti s. Curr Pharm Biotechnol. 2012 Aug;13(10):1861-7. doi: 10.2174/138920112802273281. Curr Pharm Biotechnol. 2012. PMID: 22250707 Review.

6

IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.

Galluzzo M, Boca AN, Botti E, Potenza C, Malara G, Malagoli P, Vesa S, Chimenti S, Buzoianu AD, Talamonti M, Costanzo A. Galluzzo M, et al. Among authors: chimenti s. Dermatology. 2016;232(2):230-6. doi: 10.1159/000441719. Epub 2015 Dec 18. Dermatology. 2016. PMID: 26678060

7

Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy.

Costanzo A, Talamonti M, Spallone G, Botti E, Chimenti MS, Papoutsaki M, Chimenti S. Costanzo A, et al. Among authors: chimenti ms, chimenti s. Dermatology. 2009;218(2):146-50. doi: 10.1159/000168086. Epub 2008 Oct 30. Dermatology. 2009. PMID: 18971577

8

Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21.

Capon F, Semprini S, Chimenti S, Fabrizi G, Zambruno G, Murgia S, Carcassi C, Fazio M, Mingarelli R, Dallapiccola B, Novelli G. Capon F, et al. Among authors: chimenti s. J Invest Dermatol. 2001 May;116(5):728-30. doi: 10.1046/j.1523-1747.2001.01311.x. J Invest Dermatol. 2001. PMID: 11348461 Free article.

9

Long-term treatment of plaque psoriasis with efalizumab: an Italian experience.

Costanzo A, Peris K, Talamonti M, Di Cesare A, Fargnoli MC, Botti E, Chimenti S. Costanzo A, et al. Among authors: chimenti s. Br J Dermatol. 2007 Apr;156 Suppl 2:17-23. doi: 10.1111/j.1365-2133.2007.07765.x. Br J Dermatol. 2007. PMID: 17371319

10

Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations.

Marinari B, Botti E, Bavetta M, Spallone G, Zangrilli A, Talamonti M, Richetta A, Chimenti S, Costanzo A. Marinari B, et al. Among authors: chimenti s. Drug Dev Res. 2014 Nov;75 Suppl 1:S11-4. doi: 10.1002/ddr.21186. Drug Dev Res. 2014. PMID: 25381966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page